COntinence after Robotic radical Prostatectomy with or without Alginate gel Sheet placement: randomized pivotal study

COntinence after Robotic radical Prostatectomy with or without Alginate gel Sheet placement: randomized pivotal study - CORPAS study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2012240060

Enrollment

210

Registered

2024-12-19

Start date

2025-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate cancer

Interventions

The cut dMD-002 is implanted to cover the nerve injury, tear, or defect, and is fixed by suturing to the surrounding tissue in two or more places.

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: (1) Patients diagnosed with prostate cancer (2) Patients scheduled for radical prostatectomy by robot-assisted laparoscopic surgery etc.

Exclusion criteria

Exclusion criteria: (1) Patients required radiation therapy, endocrine therapy, or antineoplastic therapy before or after radical prostatectomy (2) Patients with a history of transurethral resection, laser therapy, microwave therapy, radiofrequency ablation, or other prostate surgery (3) Patients with a history of urethral stricture incision, bladder neck incision, or surgery affecting urinary function etc.

Design outcomes

Primary

Measure	Time frame
Urinary continence rate	—

Contacts

Public ContactPublic relations

Mochida Pharmaceutical Co., Ltd.

webmaster@mochida.co.jp+81-3-3225-6303

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026